Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Apr 25 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-apr-25-2022-2

Zydus Lifesciences Limited has informed the Exchange about press release dated 25-Apr-2022 titled Zydus announces publication of ���DREAM-ND��� and ���DREAM-D��� Phase 3 trials of Desidustat in ���American Journal of Nephrology���

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases